StockData
Ionis Pharmaceuticals Inc logo

Ionis Pharmaceuticals Inc (IONS) stock

IONSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/301% below fair value
$28.01−1.05 (-3.61%)

Close on Nov 16, 2026Market cap $4.65BP/E –Yield –

Ionis Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Ionis Pharmaceuticals's total debt was $1.76B at Dec 31, 2025. For fiscal 2025 it was $1.76B, up 46.4% from the year before. Over ten years it grew 89.9% a year on average. The highest annual figure on record is $1.76B in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.76B+46.4%
FY2024Dec 31, 2024$1.20B-3.1%
FY2023Dec 31, 2023$1.24B+5.6%
FY2022Dec 31, 2022$1.18B+40.1%
FY2020Dec 31, 2020$839.57M+6.6%
FY2019Dec 31, 2019$787.53M+5627.9%
FY2018Dec 31, 2018$13.75M+748.2%
FY2017Dec 31, 2017$1.62M+36.8%
FY2016Dec 31, 2016$1.19M+130.1%
FY2015Dec 31, 2015$515.00K-82.1%
FY2014Dec 31, 2014$2.88M-34.6%
FY2013Dec 31, 2013$4.41M-9.7%
FY2012Dec 31, 2012$4.88M-96.7%
FY2011Dec 31, 2011$148.96M-3.5%
FY2010Dec 31, 2010$154.41M+880.5%
FY2009Dec 31, 2009$15.75M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$1.76B+109.6%
Q4 FY2024Dec 31, 2024$1.20B+52.7%
Q4 FY2023Dec 31, 2023$1.24B+60150.5%
Q4 FY2022Dec 31, 2022$1.18B+8047.7%
Q4 FY2020Dec 31, 2020$839.57M+5690.2%
Q4 FY2019Dec 31, 2019$787.53M+5627.9%
Q3 FY2019Sep 30, 2019$2.06M+27.1%
Q2 FY2019Jun 30, 2019$14.43M+1117.9%
Q1 FY2019Mar 31, 2019$14.50M+29491.8%
Q4 FY2018Dec 31, 2018$13.75M–
Q4 FY2017Dec 31, 2017$1.62M–
Q4 FY2016Dec 31, 2016$1.19M–
Q3 FY2016Sep 30, 2016$49.00K–

More Ionis Pharmaceuticals figures

See a number that looks wrong?